Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content

PURPOSE: Knee osteoarthritis (OA) is a common, progressively debilitating joint disease, and the intra-articular injection of autologous bone marrow concentrate (BMC) may offer a minimally invasive method of harnessing the body’s own connective tissue progenitor cells to counteract accompanying dege...

Descripción completa

Detalles Bibliográficos
Autores principales: Centeno, Christopher J., Berger, Dustin R., Money, Brandon T., Dodson, Ehren, Urbanek, Christopher W., Steinmetz, Neven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492580/
https://www.ncbi.nlm.nih.gov/pubmed/35932306
http://dx.doi.org/10.1007/s00264-022-05524-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492580/
https://www.ncbi.nlm.nih.gov/pubmed/35932306
http://dx.doi.org/10.1007/s00264-022-05524-9

Ejemplares similares